Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-014640
Filing Date
2024-11-06
Accepted
2024-11-06 16:22:57
Documents
88
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q vstm-20240930x10q.htm   iXBRL 10-Q 2031376
2 EX-31.1 vstm-20240930xex31d1.htm EX-31.1 12985
3 EX-31.2 vstm-20240930xex31d2.htm EX-31.2 13291
4 EX-32.1 vstm-20240930xex32d1.htm EX-32.1 7924
5 EX-32.2 vstm-20240930xex32d2.htm EX-32.2 7962
6 EX-99.1 vstm-20240930xex99d1.htm EX-99.1 314118
7 GRAPHIC vstm-20240930xex99d1001.jpg GRAPHIC 5205
  Complete submission text file 0001558370-24-014640.txt   9347729

Data Files

Seq Description Document Type Size
8 EX-101.SCH vstm-20240930.xsd EX-101.SCH 68260
9 EX-101.CAL vstm-20240930_cal.xml EX-101.CAL 55945
10 EX-101.DEF vstm-20240930_def.xml EX-101.DEF 307308
11 EX-101.LAB vstm-20240930_lab.xml EX-101.LAB 573400
12 EX-101.PRE vstm-20240930_pre.xml EX-101.PRE 454888
91 EXTRACTED XBRL INSTANCE DOCUMENT vstm-20240930x10q_htm.xml XML 1511586
Mailing Address 117 KENDRICK STREET SUITE 500 NEEDHAM MA 02494
Business Address 117 KENDRICK STREET SUITE 500 NEEDHAM MA 02494 (781) 292-4200
Verastem, Inc. (Filer) CIK: 0001526119 (see all company filings)

EIN.: 273269467 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35403 | Film No.: 241431385
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)